Blog

Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC

Photos of Sarah Sammons and Aditya Bardia from X and Virginia Kaklamani from sabcs.org

May 13, 2024, 09:09

Sarah Sammons: Join us for dinner and lively discussion on novel therapies for HR+ MBC

Sarah Sammons shared on X:

“Join Aditya Bardia, Virginia Kaklamani and I 6/1 for dinner and lively discussion on novel therapies for HR+ metastatic breast cancer. Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs at CCO.” .

Source: Sarah Sammons/X

Sarah Sammons is a medical oncologist at Dana-Farber’s Breast Oncology Center specializing in treating patients with all stages of breast cancer. She is particularly focusing on improving outcomes for those with metastatic breast cancer.

Through leading numerous clinical trials, she has developed new treatment options for breast cancer patients. Additionally, Dr. Sammons is skilled in treating brain metastases.

Aditya Bardia cancer CCO Dana-Farber’s Breast Oncology Center HR+/HER2- breast cancer MBC metastatic breast cancer OncoDaily Oncology Sarah Sammons SERDs Virginia Kaklamani

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers